# Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT)

> **NCT05884372** · PHASE4 · COMPLETED · sponsor: **Xi'an Honghui Hospital** · enrollment: 100 (actual)

## Conditions studied

- Osteoporosis in Postmenopausal Women

## Interventions

- **DRUG:** Eldecalcitol
- **DRUG:** Native Vitamin D
- **DRUG:** Denosumab
- **DRUG:** Calcium

## Key facts

- **NCT ID:** NCT05884372
- **Lead sponsor:** Xi'an Honghui Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-24
- **Primary completion:** 2025-07-16
- **Final completion:** 2025-07-16
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05884372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05884372, "Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05884372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*